Heavencent Therapeutics Ltd.

Heavencent Therapeutics Ltd. VISION: To avail affordable medicines to the last common man in Uganda. Core Values: Honesty, Integrity, Research and Dev't and Teamwork.

MISSION:
To distribute and market high Quality medicines from world class pharma companies. We are Heavencent Therapeutics Ltd. "a healthy you...is a wealthy you"

We are an expo-importer, wholesaler, distributor, marketing pharmaceutical company of quality finished pharmaceutical formulations.

02/08/2026

hello our esteemed customers !

Omobari Omotwe: The Ancient Kenyan🇰🇪 Traditional Gusii Head SurgeonsThe Omobari Omotwe, or traditional head surgeons of ...
01/02/2026

Omobari Omotwe: The Ancient Kenyan🇰🇪 Traditional Gusii Head Surgeons

The Omobari Omotwe, or traditional head surgeons of the Gusii tribe in Kenya, are known for their ancient practice of craniotomy, a surgical procedure to relieve pain or cure disease by drilling or boring holes into the skull. This practice has been documented for thousands of years and is still performed in some parts of Africa, including the Kisii highlands.

The Omobari Omotwe are highly skilled practitioners who undergo rigorous apprenticeship to acquire their craft. They are known for their success in treating acute cranial trauma and post-traumatic headaches, often following accidents or violent actions.

The procedure involves prayer for guidance, palpation of the head to pinpoint the incision site, and the use of herbal concoctions to minimize pain and control bleeding. Despite the risks, the Omobari Omotwe are highly respected for their skill and dedication to their profession.

01/02/2026

The Spanish team, led by researcher Dr. Manuel Serrano at the Spanish National Cancer Research Centre, has made a potential breakthrough in the fight against pancreatic cancer. Their study reveals a triple-targeted drug combination that induces complete and lasting regression of pancreatic tumours in preclinical models, addressing the challenge of treatment resistance. The therapy simultaneously targets three critical signalling pathways—RAF1, EGFR family receptors, and STAT3—vital for tumour growth and survival in pancreatic ductal adenocarcinoma (PDAC). In mouse models and human cancer tissues, the combination therapy not only shrank tumours but also prevented tumour regrowth for over 200 days without resistance. These promising results open the door for new clinical trials and may offer a safer, more effective treatment for PDAC patients in the future.

Research on street food in Kampala highlights significant health risks associated with the use of overused or reused co...
11/01/2026

Research on street food in Kampala highlights significant health risks associated with the use of overused or reused cooking oil, which can lead to food poisoning


https://x.com/i/status/2010329343478944032

Uganda registers first Sickle Cell disease cureBased on the medical experts’ reports at the US-based hospital, Byamukama...
10/01/2026

Uganda registers first Sickle Cell disease cure

Based on the medical experts’ reports at the US-based hospital, Byamukama is now the first Uganda to be completely healed of sickle cell disease after the ground-breaking treatment.

DETAILS || 👉👉newvision.co.ug/category/healt…

Address

P. O. Box 141625 1st Floor Mukansa House, Kisugu Road Kisugu South B Zone, Makindye-East. Kampala Uganda, East Africa. Mob: +256 757 856 924 (HotLine)Office: +256 393 1941 46 (Sales & Marketing)
Kampala

Opening Hours

Monday 08:30 - 17:00
Tuesday 08:30 - 17:00
Wednesday 08:30 - 17:00
Thursday 08:30 - 17:00
Friday 08:30 - 17:00
Saturday 09:00 - 12:30

Telephone

+256393194146

Website

Alerts

Be the first to know and let us send you an email when Heavencent Therapeutics Ltd. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Heavencent Therapeutics Ltd.:

Shortcuts

Share

Category